SHB: Type I (EXP): Algorithms for Unsupervised and Online Learning of Hierarchy of Features for Tuning Cochlear Implants for the Hearing Impaired
SHB: Type I (EXP): Algorithms for Unsupervised and Online Learning of Hierarchy of Features for Tuning Cochlear Implants for the Hearing Impaired
批准号:
1231620
负责人:
Bonny Banerjee
金额:
$29.82万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-01-01 至 2016-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Since noteworthy events happen only occasionally in any data, it is imperative for smart sensors to learn the norms in data so that authorities can be alerted and appropriate action can be taken at the occurrence of an abnormal or noteworthy event. The aim of this project is to develop algorithms that can learn the norm in terms of a hierarchy of meaningful features from data in an unsupervised and online manner. The application testbed is the problem of automatically tuning cochlear implants (CIs) of patients with severe-to-profound hearing loss by continuously monitoring their speech output. The working hypothesis is that deficiencies in hearing for people with significant hearing loss are reflected in their speech production. This project will develop and use unsupervised, online, and biologically plausible machine learning algorithms to learn feature hierarchies from the speech output data of severely-to-profoundly hearing-impaired patients. The learned feature hierarchy from the speech of a patient will be compared to those learned from the speech of a comparable normal hearing population. Deficiencies in the patient's hearing will be ascertained by identifying the missing or distorted features. Algorithms will be developed to map this information into the signal processing strategies used in CIs to enhance the audibility of speech.The proposed project promises transformative changes to three major interdisciplinary fields: machine learning and artificial intelligence, healthcare, and sensors. It will transform the traditional ways in which the clinical needs of patients are met. For example, the results of this project will provide doctors with evidence-based practices that will better address the specific needs of individual patients by monitoring each patient around the clock at minimal effort and cost.Hearing loss is the most common birth defect in the U.S. with slightly over 15,000 new pediatric cases each year and societal losses amounting to $4.6 billion over a lifetime. A proven technology for CI tuning would make a significant difference to the lives of over 1.2 million CI candidates in the U.S. and many more around the world, thereby leading to substantial health and economic benefits to society. Other than CI tuning, the proposed algorithms will be applicable to a variety of monitoring applications within healthcare, such as blood pressure, cerebrospinal fluid pressure, intracavitary pressure of the bladder, etc., and beyond healthcare, such as web, machine health, traffic, etc. Continuous monitoring with wearable and implantable body sensors will increase early detection of emergency conditions and diseases in at-risk patients and also provide a wide range of healthcare services for people with various degrees of cognitive and physical disabilities. Not only the elderly and chronically ill, but also the families in which both parents have to work will benefit from these systems to provide high-quality care services for their babies and children. Finally, the proposed project will integrate diversity by promoting teaching, learning, and interdisciplinary research among underrepresented groups.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
铋基邻近双金属位点Type B异质结光热催化合成氨机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:30.0万元
-
批准年份:2024
-
负责人:黎景卫
-
依托单位:
智能型Type-I光敏分子构效设计及其抗耐药性感染研究
-
批准号:22207024
-
项目类别:青年科学基金项目(C类)
-
资助金额:20.0万元
-
批准年份:2022
-
负责人:赵琦
-
依托单位:
TypeⅠR-M系统在碳青霉烯耐药肺炎克雷伯菌流行中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:蒋晓飞
-
依托单位:
替加环素耐药基因 tet(A) type 1 变异体在碳青霉烯耐药肺炎克雷伯菌中的流行、进化和传播
-
批准号:LY22H200001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:蔡加昌
-
依托单位:
面向手性α-氨基酰胺药物的新型不对称Ugi-type 反应开发
-
批准号:LY22B020003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:李绍玉
-
依托单位:
BMP9/BMP type I receptors 通过激活 PPARα保护心肌梗死的机制研究
-
批准号:LQ22H020003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:陈灵丽
-
依托单位:
C2H2-type锌指蛋白在香菇采后组织软化进程中的作用机制研究
-
批准号:32102053
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:邓冰
-
依托单位:
血管阻断型Type-I光敏剂合成及其三阴性乳腺癌光诊疗
-
批准号:62120106002
-
项目类别:国际(地区)合作与交流项目
-
资助金额:255万元
-
批准年份:2021
-
负责人:董晓臣
-
依托单位:
茶尺蠖Type-II环氧性信息素合成酶关键基因的鉴定及功能研究
-
批准号:LQ21C140001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:王倩
-
依托单位:
Chichibabin-type偶联反应在构建联氮杂芳烃中的应用
-
批准号:22078300
-
项目类别:面上项目
-
资助金额:63.0万元
-
批准年份:2020
-
负责人:李景华
-
依托单位: